Inventor · disambiguated record
Christoph Uherek
Also filed as: UHEREK CHRISTOPH
21 granted patents·5 pending applications·108 citations·filing 2008–2023
95Inventor score
Top patents by PatentIndex Score
26 records- 0194US9751934B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Sep 5, 2017·13 cites·20 claims
- 0289US10017564B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS GMBH·Filed 2016·Granted Jul 10, 2018·6 cites·21 claims
- 0389US9212228B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2012·Granted Dec 15, 2015·9 cites·42 claims
- 0488US2024117022A1Monoclonal antibodies against claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0587US10738108B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2017·Granted Aug 11, 2020·2 cites·28 claims
- 0686US10117932B2Uses of immunoconjugates targeting CD138BIOTEST AG·Filed 2012·Granted Nov 6, 2018·7 cites·46 claims
- 0786US9011864B2Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugatesSCHULZ GREGOR·Filed 2008·Granted Apr 21, 2015·19 cites·18 claims
- 0885US10174104B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Jan 8, 2019·3 cites·24 claims
- 0985US9499609B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2011·Granted Nov 22, 2016·5 cites·21 claims
- 1083US8956607B2Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)OSTERROTH FRANK·Filed 2010·Granted Feb 17, 2015·7 cites·15 claims
- 1182US9289509B2Uses of immunoconjugates targeting CD138OSTERROTH FRANK·Filed 2010·Granted Mar 22, 2016·10 cites·49 claims
- 1281US9446146B2Methods and agents for improving targeting of CD138 expressing tumor cellsDAELKEN BENJAMIN·Filed 2008·Granted Sep 20, 2016·10 cites·10 claims
- 1381US9221914B2Agents targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Dec 29, 2015·6 cites·10 claims
- 1477US9387261B2Immunoconjugates targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Jul 12, 2016·4 cites·18 claims
- 1575US11739139B2Monoclonal antibodies against Claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2020·Granted Aug 29, 2023·0 cites·18 claims
- 1675US8852871B2Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)OSTERROTH FRANK·Filed 2010·Granted Oct 7, 2014·3 cites·21 claims
- 1769US9334325B2Method for treating psoriasisOSTERROTH FRANK·Filed 2010·Granted May 10, 2016·2 cites·13 claims
- 1864US9995733B2Agents for treating diseaseOSTERROTH FRANK·Filed 2012·Granted Jun 12, 2018·1 cites·28 claims
- 1961US9605066B2Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)BIOTEST AG·Filed 2014·Granted Mar 28, 2017·0 cites·14 claims
- 2059US9550831B2Method for treating psoriasisAIGNER SILKE·Filed 2010·Granted Jan 24, 2017·1 cites·13 claims
- 2156US2019117770A1Uses of immunoconjugates targeting cd138BIOTEST AG·Filed 2018·Application pending·0 cites
- 2252US9540436B2Use of antibodies for detection of IL-10BIOTEST AG·Filed 2015·Granted Jan 10, 2017·0 cites·14 claims
- 2343US2017081418A1Immunoconjugates targeting cd138 and uses thereofBIOTEST AG·Filed 2016·Application pending·0 cites
- 2441US2016185854A1Agents targeting cd138 and uses thereofBIOTEST AG·Filed 2015·Application pending·0 cites
- 2534US2011229465A1Composition for treating diseaseOSTERROTH FRANK·Filed 2011·Application pending·0 cites
- 2630US9512226B2Agent for treating diseaseGERMER MATTHIAS·Filed 2010·Granted Dec 6, 2016·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →